Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
Bachmann MF, Jennings GT. Bachmann MF, et al. Nat Rev Immunol. 2010 Nov;10(11):787-96. doi: 10.1038/nri2868. Epub 2010 Oct 15. Nat Rev Immunol. 2010. PMID: 20948547 Review.
Challenges and new approaches for the vaccine industry.
Bachmann MF, Jennings GT. Bachmann MF, et al. Drug Discov Today. 2001 Jun 1;6(11):566-568. doi: 10.1016/s1359-6446(01)01811-6. Drug Discov Today. 2001. PMID: 11377223 No abstract available.
A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses.
Jegerlehner A, Tissot A, Lechner F, Sebbel P, Erdmann I, Kündig T, Bächi T, Storni T, Jennings G, Pumpens P, Renner WA, Bachmann MF. Jegerlehner A, et al. Vaccine. 2002 Aug 19;20(25-26):3104-12. doi: 10.1016/s0264-410x(02)00266-9. Vaccine. 2002. PMID: 12163261
Virus-like particles as a modular system for novel vaccines.
Lechner F, Jegerlehner A, Tissot AC, Maurer P, Sebbel P, Renner WA, Jennings GT, Bachmann MF. Lechner F, et al. Intervirology. 2002;45(4-6):212-7. doi: 10.1159/000067912. Intervirology. 2002. PMID: 12566703 Review.
A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity.
Maurer P, Jennings GT, Willers J, Rohner F, Lindman Y, Roubicek K, Renner WA, Müller P, Bachmann MF. Maurer P, et al. Eur J Immunol. 2005 Jul;35(7):2031-40. doi: 10.1002/eji.200526285. Eur J Immunol. 2005. PMID: 15971275 Clinical Trial.
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.
Kündig TM, Senti G, Schnetzler G, Wolf C, Prinz Vavricka BM, Fulurija A, Hennecke F, Sladko K, Jennings GT, Bachmann MF. Kündig TM, et al. J Allergy Clin Immunol. 2006 Jun;117(6):1470-6. doi: 10.1016/j.jaci.2006.01.040. Epub 2006 Apr 27. J Allergy Clin Immunol. 2006. PMID: 16751015 Clinical Trial.
Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.
Röhn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF. Röhn TA, et al. Eur J Immunol. 2006 Nov;36(11):2857-67. doi: 10.1002/eji.200636658. Eur J Immunol. 2006. PMID: 17048275
A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis.
Spohn G, Guler R, Johansen P, Keller I, Jacobs M, Beck M, Rohner F, Bauer M, Dietmeier K, Kündig TM, Jennings GT, Brombacher F, Bachmann MF. Spohn G, et al. J Immunol. 2007 Jun 1;178(11):7450-7. doi: 10.4049/jimmunol.178.11.7450. J Immunol. 2007. PMID: 17513796
40 results
Jump to page
Feedback